J. Cesaretti

发表

Update on Prostate Brachytherapy: Long-term Outcomes and Treatment-related Morbidity

R. Stock, N. Stone, J. Kao, 2011, Current urology reports.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Petra Seibold, Hubert Thierens, Alison M Dunning, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer.

J. Cesaretti, D. Swartz, C. Vargas, 2019, Cancer treatment and research communications.

ATM sequence variants and adverse radiotherapy response in breast cancer patients

R. Stock, J. Overgaard, J. Alsner, 2004 .

ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.

Jens Overgaard, Barry S Rosenstein, Jan Alsner, 2006, International journal of radiation oncology, biology, physics.

Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation

R. Stock, N. Stone, J. Cesaretti, 2006, BJU international.

Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases

E. Genden, M. Galsky, R. Stock, 2012, PloS one.

Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.

R. Stock, N. Stone, J. Cesaretti, 2006, International journal of radiation oncology, biology, physics.

Combined modality treatment in the management of high-risk prostate cancer.

R. Stock, N. Stone, J. Cesaretti, 2004, International journal of radiation oncology, biology, physics.

Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control.

R. Stock, N. Stone, J. Cesaretti, 2006, International journal of radiation oncology, biology, physics.

Adjuvant radiotherapy improves overall survival for patients with lymph node‐positive head and neck squamous cell carcinoma

E. Genden, J. Kao, J. Cesaretti, 2008, Cancer.

Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes.

P. Unger, R. Stock, N. Stone, 2008, International journal of radiation oncology, biology, physics.

Genome-Wide Association Study Identifies a Region on Chromosome 11q14.3 Associated With Late Rectal Bleeding Following Radiation Therapy for Prostate Cancer

H. Ostrer, R. Stock, N. Stone, 2013 .

Outcomes for patients with high‐grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy

R. Stock, N. Stone, J. Cesaretti, 2009, BJU international.

Does prior transurethral resection of prostate compromise brachytherapy quality: a dosimetric analysis.

R. Stock, N. Stone, J. Cesaretti, 2004, International journal of radiation oncology, biology, physics.

The Role of MRI in Radiation Therapy Planning

J. Cesaretti, S. Schoeppel, M. Koshy, 2011 .

Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.

R. Stock, N. Stone, J. Cesaretti, 2009, International journal of radiation oncology, biology, physics.

Adjuvant radiation with modern techniques is the standard of care for stage III thymoma.

J. Cesaretti, 2006, The Annals of thoracic surgery.

Brachytherapy for the Treatment of Prostate Cancer

R. Stock, N. Stone, J. Cesaretti, 2007, Cancer journal.

Erratum: Phase 1 study of concurrent sunitinib and image‐guided radiotherapy followed by maintenance sunitinib for patients with oligometastases

R. Stock, Y. Lo, J. Kao, 2011 .

Phase 1 study of concurrent sunitinib and image‐guided radiotherapy followed by maintenance sunitinib for patients with oligometastases

R. Stock, Y. Lo, J. Kao, 2009, Cancer.

There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.

R. Stock, N. Stone, J. Cesaretti, 2009, International journal of radiation oncology, biology, physics.

Urinary symptom flare following I-125 prostate brachytherapy.

R. Stock, N. Stone, J. Cesaretti, 2003, International journal of radiation oncology, biology, physics.

ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.

R. Stock, N. Stone, S. Wallenstein, 2004, International journal of radiation oncology, biology, physics.

Effect of low dose‐rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at ≥ 7 years of follow‐up

R. Stock, N. Stone, J. Kao, 2007, BJU international.

The influence of stigma on the quality of life for prostate cancer survivors

Andrew W. Wood, J. Cesaretti, Sejal M. Barden, 2017, Journal of psychosocial oncology.

Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.

R. Stock, J. Bernstein, J. Cesaretti, 2007, International journal of radiation oncology, biology, physics.

A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.

Christopher A Peters, Barry S Rosenstein, R. Stock, 2007, International journal of radiation oncology, biology, physics.

Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.

R. Stock, A. Kuten, J. Overgaard, 2006, International journal of radiation oncology, biology, physics.

Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer.

R. Stock, N. Stone, J. Cesaretti, 2010, International journal of radiation oncology, biology, physics.

Young Men have Equivalent Biochemical Outcomes Compared to Older Men After Treatment With Prostate Brachytherapy

R. Stock, N. Stone, J. Cesaretti, 2007 .

A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.

Richard Stock, Yongzhao Shao, Dirk De Ruysscher, 2013, International journal of radiation oncology, biology, physics.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5,456 breast and prostate cancer patients

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

ATM rs1801516 SNP and toxicity after radiotherapy

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.

H. Ostrer, R. Stock, N. Stone, 2013, Radiotherapy and Oncology.

Association of Single Nucleotide Polymorphisms in SOD2, XRCC1 and XRCC3 with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate Cancer

Christopher A Peters, Barry S Rosenstein, Grace Fan, 2008, Radiation research.

Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer.

R. Stock, N. Stone, J. Cesaretti, 2007, Brachytherapy.

Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.

R. Stock, N. Stone, J. Cesaretti, 2009, International journal of radiation oncology, biology, physics.

Disease-specific survival following the brachytherapy management of prostate cancer.

R. Stock, N. Stone, J. Cesaretti, 2006, International journal of radiation oncology, biology, physics.

Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.

Barry S Rosenstein, R. Stock, N. Stone, 2005, International journal of radiation oncology, biology, physics.

Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapy.

R. Stock, J. Cesaretti, M. Terk, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.

P. Unger, R. Stock, N. Stone, 2008, Brachytherapy.

Stereotactic radiosurgery for thoracic malignancies.

J. Cesaretti, B. Rosenstein, H. Fernando, 2008, The Annals of thoracic surgery.

Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer.

Evan B. Garden, R. Stock, J. Cesaretti, 2020, Urologic oncology.

Prostate cancer: the influence of stigma on quality of life and relationship satisfaction for survivors and their partners

Andrew W. Wood, J. Cesaretti, Sejal M. Barden, 2019, Journal of psychosocial oncology.

Do high radiation doses in locally advanced prostate cancer patients treated with 103Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity?

R. Stock, N. Stone, J. Cesaretti, 2008, Brachytherapy.

TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.

H. Ostrer, R. Stock, N. Stone, 2008, International journal of radiation oncology, biology, physics.

Salvage brachytherapy for recurrent prostate cancer.

J. Cesaretti, D. Swartz, C. Vargas, 2014, Brachytherapy.

Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?

R. Stock, N. Stone, J. Cesaretti, 2010, The Journal of urology.

Comparisons of PSA Failure Definitions Following Trimodality Therapy for Intermediate to High-Risk Prostate Cancer

R. Stock, N. Stone, J. Cesaretti, 2007 .

Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

R. Stock, N. Stone, J. Cesaretti, 2003, International journal of radiation oncology, biology, physics.

Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.

R. Stock, N. Stone, J. Cesaretti, 2005, The Journal of urology.

(125)I monotherapy using D90 implant doses of 180 Gy or greater.

R. Stock, N. Stone, V. Dumane, 2008, International journal of radiation oncology, biology, physics.

Acceptability and Preliminary Feasibility of an Internet/CD-ROM-Based Education and Decision Program for Early-Stage Prostate Cancer Patients: Randomized Pilot Study

Richard Stock, Natan Bar-Chama, M. Diefenbach, 2012, Journal of medical Internet research.

Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.

R. Stock, N. Stone, J. Cesaretti, 2005, Brachytherapy.

Single Nucleotide Polymorphisms as Predictors for Development of Erectile Dysfunction in African-American Men Treated With Radiotherapy for Prostate Cancer

R. Stock, N. Stone, J. Cesaretti, 2007 .

Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer.

A. Neugut, J. Cesaretti, J. Wisnivesky, 2011, International journal of radiation oncology, biology, physics.

The influence of stigma on the quality of life for prostate cancer survivors

Andrew W. Wood, J. Cesaretti, Sejal M. Barden, 2017, Journal of psychosocial oncology.

Outcomes for patients with high‐grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy

R. Stock, N. Stone, J. Cesaretti, 2009, BJU international.

Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.

R. Stock, N. Stone, J. Cesaretti, 2009, International journal of radiation oncology, biology, physics.

Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.

P. Unger, R. Stock, N. Stone, 2008, Brachytherapy.

Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer.

Evan B. Garden, R. Stock, J. Cesaretti, 2022, Urologic oncology.